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Herewith we are submitting an Article, focused on a new mutation found in the GJB2 gene. 
This mutation, p.Leu213X, introduces a premature STOP codon avoiding the formation of the 
functional connexin 26 protein and in the present study was found in compound heterozygosity with 
another GJB2 mutation already identified (c.333-334delAA), being this genotype responsible for the 
hearing impairment observed in the two patients.  
All the co-authors have been involved in the study and have other publications in the field of 
Hereditary Deafness published in different journals as Genetics Research International, Am J Med 
Genet, Hear Research., Int J Ped Otorhinolaryngology, Eur J Hum Genet, J Med Genet. 
The corresponding author is: 
Helena Caria (helena.caria@ess.ips.pt);  
Phone: +351919661584  
Fax number: + 351 265 709 392. 
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Introduction: Hearing loss is the most common sensory disability and is present in about 1.9 
per 1000 infants at birth. The DFNB1 locus (13q11-q12) includes the genes GJB2, coding for 
connexin 26, and GJB6, encoding connexin 30. More than 100 mutations have been identified 
associated with autosomal dominant and recessive hearing loss in the GJB2 gene.  
Objectives: The aim of the present study was to identify the genetic etiology of deafness in two 
Portuguese individuals, presenting nonsyndromic sensorineural moderate and severe hearing 
loss, respectively.  
Patients and Methods: The individuals were evaluated in both ears by pure tone audiometry 
and blood samples were collected after written informed consent was signed. DNA extraction 
and PCR amplification of GJB2 coding region followed standard methodologies. PCR products 
were automatically sequenced in both directions. 
Results:We identified a novel mutation, c.638T>A (p.Leu213X), in GJB2 gene. This nonsense 
mutation was found in both siblings, and was inherited from their hearing father. Molecular 
analysis showed that the two siblings were also heterozygous for c.333-334delAA, a previously 
described GJB2 deletion. This novel mutation was not found in a random control sample of 480 
individuals that were screened for coding region of GJB2 gene. p.Leu213X mutation identified 
in this study for the first time changes the codon 213, coding for a highly conserved and slowly 
evolving residue of connexin 26, localised to the C-terminus domain of the protein, to a stop 
codon, leading to the deletion of the last 14 amino acids of the protein. 
Conclusion: We can conclude that the etiology of deafness in these individuals is due to the 
















































































Clinically significant hearing loss (HL) is present in at least 1.9 per 1000 infants at birth 
and the prevalence rises to at least 2.7 per 1000 by the age of four [1]. HL may be due to genetic 
and/or non-genetic (environmental) factors. Most hereditary HL is inherited as a simple 
Mendelian trait and is nonsyndromic (70%), being classified as sensorineural when it is caused 
by problems in the inner ear, cochlear nerve, and/or central auditory pathway [2]. 
Nonsyndromic sensorineural hearing loss (NSSHL) is predominantly inherited in an autosomal 
recessive pattern (DFNB loci). The DFNB1 locus, at chromosome 13q11-q12, includes the 
GJB2 and GJB6 genes, which encode connexin 26 (Cx26) and connexin 30 (Cx30), 
respectively. These connexin proteins are co-expressed and co-localised in the cochlea, where 
they are constituents of the cochlear gap junction systems, which are thought to have a role in 
the recirculation of K
+
 contributing to cochlear homeostasis [3,4,5], and might also be important 
for Ca
2+
 signalling [6] and the intracellular diffusion of large cationic molecules [7]. 
GJB2 gene is about 5500 bp length with 2 exons, of which only one contains the coding 
region [8]. More than 100 different mutations have been identified in association with 
autosomal dominant and recessive HL in this gene [8]. Three nonsyndromic recessive 
mutations, c.35delG, c.167delT and c.235delC have been found at high frequency in Caucasian, 
Ashkenazi Jewish, and Asian populations, respectively [9]. 
 
Methods 
We studied one Portuguese family, composed of two hearing-impaired siblings with 
HL, aged 11 and 15 (proband) years and their normal hearing parents (fig. 1A). Each affected 
individual was clinically evaluated to ensure that the HL was not syndromic neither a result of 
infection, acoustic trauma, ototoxic drugs or premature birth. None of the patients had 
undergone cochlear implantation.  
Written informed consent was obtained from siblings and parents prior to blood 
sampling. Hearing levels were determined by pure-tone audiometry with a diagnostic 


































































Working Group on Genetics of Hearing Impairment [10], as mild (21–40 dB), moderate (41–70 
dB), severe (71–95 dB), or profound (>95 dB), from an average at 500, 1000, 2000 and 4000 Hz 
in the better ear. Total genomic DNA was extracted from peripheral blood using the JetQuick 
Blood and Cell Culture Kit (GENOMED), according to the manufacturer’s instructions. PCR 
amplification of GJB2 coding exon was made using primers 2AF and 2BR described previously 
[11]. After direct bidirectional sequencing electrophoretograms were evaluated by visual 
inspection and pairwise alignment to reference sequences using NCBI’s BLAST (Basic Local 
Alignment Search Tool) [12]. A random control sample composed of 480 Portuguese 
individuals was also screened for the coding region of GJB2 gene. 
 
Results 
Pure tone audiometry showed bilateral, sensorineural moderate and severe HL in the 
proband (individual II:1) and his sibling (individual II:2), respectively (fig. 1D,E). Both parents 
had normal hearing (fig. 1B,C). A novel variant, c.638T>A (p.Leu213X) was found through 
molecular genetic analysis in the two siblings in compound heterozygosity with the c.333-
334delAA previously described deletion. The deletion c.333-334delAA (fig. 2A,B) was 
inherited from the mother, who is heterozygous for this mutation. The novel mutation 
p.Leu213X (fig. 2C,D) found in both siblings, was later identified in their father, in 
heterozygosity. This new mutation was not present in the random control sample of 480 
Portuguese individuals that were screened for coding region of GJB2 gene. 
 
Discussion 
Mutations in GJB2 are the most common cause of nonsyndromic, autosomal recessive, 
hereditary HL, and may account for 10–40% of all congenital HL depending upon ethnicity [9]. 
The recessive deletion c.333-334delAA [13] causes a frameshift which results in chain 
termination after an additional novel amino acid, truncating about half of the protein. This is the 


































































The novel recessive mutation p.Leu213X, found in this study, creates a premature 
STOP codon by changing the codon 213 (TTG) which codes for a leucine, for a STOP codon 
(TAG). This mutation leads to the deletion of the last 14 amino acids of the protein. The Leu213 
amino acid residue is localised to the C-terminus domain of the protein. The residues in the 
intracellular loop region and C-terminus are very different among different connexins and are 
hence thought to be responsible for regulation. These residues could thus impart unique 
properties to the various connexin molecules [14]. According to ConSeq [15] the mutation 
p.Leu213X affects a highly conserved residue that has evolved slowly (fig. 3).  
Previously to this study, seven other missense/nonsense mutations were found in the C-
terminus of Cx26 [16]. Interestingly, one of those mutations, identified in French patients [17], 
is also a nonsense mutation, p.Cys211X, occurring close to p.213LeuX and eliminating the 




Considering all this, we can conclude that the HL of the two Portuguese siblings is most 
probably due to the presence of the c.333-334delAA deletion and the p.Leu213X novel 
mutation, in compound heterozygosity. However, the functional characterization of the 
p.Leu213X nonsense mutation should be performed in order to investigate the effect of the 
mutation on the protein, and to provide insight on the role of the conserved 213Leu residue and 










































































Figure 1 – Pedigree of the family analysed in this study (A). Representative audiograms of 
individual I:2 (B), individual I:1 (C), individual II:1 (D) and individual II:2 (E) showing pure-
tone audiometry results for air conduction bilaterally. Circles in blue represent the right ear; 
crosses in red represent the left ear.  
 
Figure 2 – Partial sequence of an electrophoretogram showing (A) wild-type sequence and (B) 
the c.333-334delAA heterozygous deletion (the arrow). Partial sequence of an 
electrophoretogram showing (C) the wild-type sequence and (D) the novel mutation identified 
in this study, p.Leu213X, in heterozygosity (arrow). 
 
Figure 3 – Schematic representation of the Cx26 protein showing the two mutations identified 
in this study. The extent of amino acid conservation is colour-coded, with residues shown in 
shades of blue (1-2) not conserved and rapidly evolving. Residues in white (3-6) show an 
average degree of conservation and residues in shades of red (7-9) are highly conserved and are 
slowly evolving. The degree of conservation of the polymorphic residues was analysed using 
ConSeq [15], the sequence only variant of Rate4Site, an algorithmic tool for the identification 
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